IL17RA | Interleukin 17 receptor A | CD markers Disease related genes Predicted membrane proteins
| | ![](/images/24996/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/24996/59800_B_8_1_rna_selected_60x60.jpg) | Mixed |
CECR2 | Cat eye syndrome chromosome region, candidate 2 | | | ![](/images/2943/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2943/7928_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
ATP6V1E1 | ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1 | Plasma proteins Transporters
| | ![](/images/29196/if_selected_60x60.jpg) | ![](/images/29196/ihc_cell_selected_60x60.jpg) | ![](/images/29196/103294_B_6_4_rna_selected_60x60.jpg) | Expressed in all |
BID | BH3 interacting domain death agonist | Mitochondrial proteins
| | | | ![](/images/3771/10350_A_5_1_rna_selected_60x60.jpg) | Expressed in all |
MICAL3 | Microtubule associated monooxygenase, calponin and LIM domain containing 3 | Cytoskeleton related proteins Predicted membrane proteins
| ![](/images/639/ihc_selected_60x60.jpg) | | ![](/images/639/ihc_cell_selected_60x60.jpg) | ![](/images/3421/62767_A_1_4_rna_selected_60x60.jpg) | Expressed in all |
PEX26 | Peroxisomal biogenesis factor 26 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/70429/151321_B_1_7_rna_selected_60x60.jpg) | Expressed in all |
PRODH | Proline dehydrogenase (oxidase) 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/20361/105357_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
DGCR14 | DiGeorge syndrome critical region gene 14 | | | ![](/images/1221/if_selected_60x60.jpg) | ![](/images/1222/ihc_cell_selected_60x60.jpg) | ![](/images/1221/3366_B_8_4_rna_selected_60x60.jpg) | Expressed in all |
HIRA | Histone cell cycle regulator | | | | | ![](/images/39243/83223_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
MRPL40 | Mitochondrial ribosomal protein L40 | Mitochondrial proteins Plasma proteins
| | | ![](/images/6181/ihc_cell_selected_60x60.jpg) | ![](/images/6181/18187_B_9_4_rna_selected_60x60.jpg) | Expressed in all |
UFD1L | Ubiquitin fusion degradation 1 like (yeast) | Transporters
| ![](/images/30287/ihc_selected_60x60.jpg) | | ![](/images/30287/ihc_cell_selected_60x60.jpg) | ![](/images/30287/67552_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
CDC45 | Cell division cycle 45 | Plasma proteins Predicted secreted proteins
| | | ![](/images/614/ihc_cell_selected_60x60.jpg) | ![](/images/9459/25843_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
GNB1L | Guanine nucleotide binding protein (G protein), beta polypeptide 1-like | | | ![](/images/34628/if_selected_60x60.jpg) | ![](/images/34627/ihc_cell_selected_60x60.jpg) | ![](/images/34627/67582_A_3_5_rna_selected_60x60.jpg) | Mixed |
TXNRD2 | Thioredoxin reductase 2 | Enzymes Mitochondrial proteins Plasma proteins
| | | ![](/images/3323/ihc_cell_selected_60x60.jpg) | ![](/images/3323/10576_B_9_4_rna_selected_60x60.jpg) | Expressed in all |
COMT | Catechol-O-methyltransferase | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | ![](/images/1169/if_selected_60x60.jpg) | | ![](/images/11233/26802_A_3_6_rna_selected_60x60.jpg) | Expressed in all |
ARVCF | Armadillo repeat gene deleted in velocardiofacial syndrome | | ![](/images/16162/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/16162/35845_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
DGCR8 | DGCR8 microprocessor complex subunit | Plasma proteins
| ![](/images/19965/ihc_selected_60x60.jpg) | | ![](/images/19965/ihc_cell_selected_60x60.jpg) | ![](/images/19965/45953_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
TRMT2A | TRNA methyltransferase 2 homolog A (S. cerevisiae) | Plasma proteins
| ![](/images/1077/ihc_selected_60x60.jpg) | ![](/images/1077/if_selected_60x60.jpg) | | ![](/images/1077/2594_B_7_7_rna_selected_60x60.jpg) | Expressed in all |
RANBP1 | RAN binding protein 1 | Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46463/111547_B_8_4_rna_selected_60x60.jpg) | Expressed in all |
RTN4R | Reticulon 4 receptor | Predicted membrane proteins
| ![](/images/12443/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/12443/27673_A_6_1_rna_selected_60x60.jpg) | Tissue enhanced |
GGTLC3 | Gamma-glutamyltransferase light chain 3 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47534/115764_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
ZNF74 | Zinc finger protein 74 | Transcription factors
| ![](/images/3354/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/3354/9266_B_9_2_rna_selected_60x60.jpg) | Mixed |
SCARF2 | Scavenger receptor class F, member 2 | Disease related genes Predicted membrane proteins
| | ![](/images/35079/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/35079/72234_B_9_1_rna_selected_60x60.jpg) | Mixed |
MED15 | Mediator complex subunit 15 | | | | ![](/images/3179/ihc_cell_selected_60x60.jpg) | ![](/images/3179/8497_B_7_1_rna_selected_60x60.jpg) | Expressed in all |
SERPIND1 | Serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/8639/21739_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |
SNAP29 | Synaptosomal-associated protein, 29kDa | Disease related genes
| | | ![](/images_static/rna_center.gif) | ![](/images/31823/67116_A_1_6_rna_selected_60x60.jpg) | Expressed in all |
CRKL | V-crk avian sarcoma virus CT10 oncogene homolog-like | Plasma proteins
| ![](/images/1100/ihc_selected_60x60.jpg) | ![](/images/1100/if_selected_60x60.jpg) | | ![](/images/1100/2417_B_7_7_rna_selected_60x60.jpg) | Expressed in all |
P2RX6 | Purinergic receptor P2X, ligand-gated ion channel, 6 | Predicted membrane proteins
| | ![](/images/28776/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/28777/60883_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
GGT2 | Gamma-glutamyltransferase 2 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45635/103736_A_2_5_rna_selected_60x60.jpg) | Tissue enhanced |
UBE2L3 | Ubiquitin-conjugating enzyme E2L 3 | Enzymes Plasma proteins
| ![](/images/45609/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/45609/102213_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
SDF2L1 | Stromal cell-derived factor 2-like 1 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/5638/15825_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
PPIL2 | Peptidylprolyl isomerase (cyclophilin)-like 2 | Enzymes
| | | ![](/images_static/rna_center.gif) | ![](/images/35344/73529_B_8_4_rna_selected_60x60.jpg) | Expressed in all |
MAPK1 | Mitogen-activated protein kinase 1 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins RAS pathway related proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/5700/20814_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
TOP3B | Topoisomerase (DNA) III beta | Enzymes Plasma proteins
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Expressed in all |
GGTLC2 | Gamma-glutamyltransferase light chain 2 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45635/103738_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
BCR | Breakpoint cluster region | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | ![](/images/38337/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/38337/81434_B_8_7_rna_selected_60x60.jpg) | Expressed in all |
ZNF70 | Zinc finger protein 70 | Transcription factors
| ![](/images/18821/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/18821/41348_B_9_2_rna_selected_60x60.jpg) | Mixed |
VPREB3 | Pre-B lymphocyte 3 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3041/8933_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
CHCHD10 | Coiled-coil-helix-coiled-coil-helix domain containing 10 | Mitochondrial proteins
| ![](/images/3440/ihc_selected_60x60.jpg) | | | ![](/images/3440/10754_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
MMP11 | Matrix metallopeptidase 11 (stromelysin 3) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2593/10111_B_8_7_rna_selected_60x60.jpg) | Group enriched |
SMARCB1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | ![](/images/18248/40946_A_4_2_rna_selected_60x60.jpg) | Expressed in all |
MIF | Macrophage migration inhibitory factor (glycosylation-inhibiting factor) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | ![](/images/5284/13361_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
SUSD2 | Sushi domain containing 2 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4117/24523_A_3_5_rna_selected_60x60.jpg) | Tissue enhanced |
SNRPD3 | Small nuclear ribonucleoprotein D3 polypeptide 18kDa | Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/1170/3543_B_7_4_rna_selected_60x60.jpg) | Expressed in all |
GGT1 | Gamma-glutamyltransferase 1 | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45635/103738_A_9_6_rna_selected_60x60.jpg) | Tissue enhanced |
SGSM1 | Small G protein signaling modulator 1 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3986/12493_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
MYO18B | Myosin XVIIIB | | ![](/images/953/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/953/2436_B_8_2_rna_selected_60x60.jpg) | Group enriched |
TPST2 | Tyrosylprotein sulfotransferase 2 | Enzymes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/21054/47688_B_9_5_rna_selected_60x60.jpg) | Expressed in all |
CHEK2 | Checkpoint kinase 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| ![](/images/1878/ihc_selected_60x60.jpg) | | | ![](/images/1878/7340_A_2_1_rna_selected_60x60.jpg) | Mixed |
HSCB | HscB mitochondrial iron-sulfur cluster co-chaperone | Mitochondrial proteins
| | | ![](/images/18447/ihc_cell_selected_60x60.jpg) | ![](/images/18447/47051_B_7_8_rna_selected_60x60.jpg) | Expressed in all |